Indraprastha Medical (INDRAMEDCO) — Annual Report

📢 Key Event
INDRAMEDCO proposes ₹4 per share dividend for FY2025-26, payable after September 24, 2026 AGM to shareholders on record as of September 18, 2026.

🔄 What Changed
Profit before tax increased 14% to ₹246.02 Crore; profit after tax rose 14% to ₹183.62 Crore; dividend recommended at ₹4 per share (40% on ₹10 face value); market capitalization stands at ₹3,413.44 Crore as of March 31, 2026.

🔮 What's Next
Dividend will be paid within 30 days of the September 24, 2026 AGM; record date for dividend eligibility is September 18, 2026; e-voting via NSDL is available for AGM participation; CSR spending must meet 2% net profit requirement annually with no unspent amounts carried forward.

💡 Investor Takeaway
The company demonstrates strong profitability growth and shareholder-friendly dividend policy, but faces governance concerns around unmet SEBI director approval rules and pending government share dematerialization requirements.

Indraprastha Medical Corporation Limited (INDRAMEDCO) reported a 14% rise in profit before tax to [amount context mismatch] Crore and profit after tax to ₹183.62 Crore for FY2025-26, recommending a ₹4 per share dividend (40% on ₹10 face value) payable within 30 days of the September 24, 2026 AGM to shareholders on record as of September 18, 2026. The company maintains a ₹3,413.44 Crore market capitalization, operates 78 hospitals and 2,501 diagnostic centers, and recorded ₹1,482.51 Crore revenue. No material changes occurred between March 31, 2026, and the report date, with no subsidiaries or joint ventures. The filing confirms unclaimed dividends transferred to IEPF after 7 years, mandatory KYC updates for physical shareholders, and e-voting instructions via NSDL for the AGM. Governance disclosures note SEBI compliance, unqualified audit opinion, and no fraud reported, while ESG initiatives target 10% energy reduction and 25% renewable energy adoption by 2026-27.

📄 View Original Announcement (PDF)

📊 Stock Analysis — INDRAMEDCO ✨ Ask AI About This

About Indraprastha Medical Corporation Ltd (INDRAMEDCO)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹3,279.6 Cr P/E: 17.4 ROE: 31.5% ROCE: 43.4% Div Yield: 1.12%

View full INDRAMEDCO stock details →

📡 Get AI alerts when INDRAMEDCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDRAMEDCO — Free

💡 Ask AI about this filing

"What is the exact date and time of the AGM voting window?" "How will the government's non-dematerialized shares affect trading liquidity?" "What is the company's plan to meet the 25% renewable energy target by 2026-27?"

Ask AI Free →

📊 More INDRAMEDCO filings

See all INDRAMEDCO filings →

🔥 Also filed on 1 September 2026

544083 Shree Marutinandan Tubes Ltd Annual Report SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement FORTIS Fortis Healthcare Ltd Announcement JNPR Juniper Green Energy Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDRAMEDCO files new disclosures

Track INDRAMEDCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDRAMEDCO — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd